Status:
COMPLETED
4D-flow MRI to Assess Left Ventricular Obstruction in Hypertrophic Cardiomyopathy
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Conditions:
Hypertrophic Cardiomyopathy
Obstruction
Eligibility:
All Genders
18+ years
Brief Summary
Hypertrophic cardiomyopathy (HCM) is a frequent cardiac pathology with an estimated prevalence of 1/500 in France. The main risk factor for sudden death in this pathology is the presence and extent of...
Eligibility Criteria
Inclusion
- Age ≥ 18 years old
- Presence of a Hypertrophic cardiomyopathy (HCM)
- Affiliation to a social security program
- Ability of the subject to understand and express opposition
Exclusion
- Major obesity (\> 140 kg) not allowing the patient to enter the tunnel of the machine whose diameter is less than 70cm,
- Age \< 18,
- Person under guardianship or curators,
- Pregnant woman,
- Allergy to gadolinium chelates,
- Claustrophobia,
- Any contraindications to MRI
Key Trial Info
Start Date :
June 17 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2023
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT04439942
Start Date
June 17 2020
End Date
June 1 2023
Last Update
August 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Amiens
Amiens, France, 80480